Fawzy Elbarbry

Dr. Fawzy Elbarbry

Pacific University Oregon
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Ashim MalhotraAshim Malhotra
Ashim Malhotra
SBSundeep Bath
Sundeep Bath
Fawzy ElbarbryFawzy Elbarbry
Fawzy Elbarbry
Resveratrol is a phenolic phytochemical, with a stilbene backbone, derived from edible plants such as grape and peanut. It is a bioactive molecule with physiological effects on multiple organ systems. Its effects range from the neuroprotective to the nephroprotective, including cardiovascular, neuronal, and antineoplastic responses as a part of its broad spectrum of action. In this review, we examine the effects of resveratrol on the following organ systems: the central nervous system, including neurological pathology such as Parkinson’s and Alzheimer’s disease; the cardiovascular system, including disorders such as atherosclerosis, ischemia-reperfusion injury, and cardiomyocyte hypertrophy; the kidneys, including primary and secondary nephropathies and nephrolithiasis; multiple forms of cancer; and metabolic syndromes including diabetes. We emphasize commonalities in extracellular matrix protein alterations and intracellular signal transduction system induction following resveratrol treatment. We summarize the known anti-inflammatory, antioxidative, and cytoprotective effects of resveratrol across disparate organ systems. Additionally, we analyze the available literature regarding the pharmacokinetics of resveratrol formulations used in these studies. Finally, we critically examine select clinical trials documenting a lack of effect following resveratrol treatment.

28 January 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Nicola CarterNicola Carter
Nicola Carter
Brendan StamperBrendan Stamper
Brendan Stamper
Fawzy ElbarbryFawzy Elbarbry
Fawzy Elbarbry
Vince NguyenVince Nguyen
Vince Nguyen
SLSamuel Lopez
Samuel Lopez
Sigrid RobertsSigrid Roberts
Sigrid Roberts
Parasites of the genus Leishmania cause a variety of devastating and often fatal diseases in humans worldwide. Because a vaccine is not available and the currently small number of existing drugs are less than ideal due to lack of specificity and emerging drug resistance, the need for new therapeutic strategies is urgent. Natural products and their derivatives are being used and explored as therapeutics and interest in developing such products as antileishmanials is high. The enzyme arginase, the first enzyme of the polyamine biosynthetic pathway in Leishmania, has emerged as a potential therapeutic target. The flavonols quercetin and fisetin, green tea flavanols such as catechin (C), epicatechin (EC), epicatechin gallate (ECG), and epigallocatechin-3-gallate (EGCG), and cinnamic acid derivates such as caffeic acid inhibit the leishmanial enzyme and modulate the host’s immune response toward parasite defense while showing little toxicity to the host. Quercetin, EGCG, gallic acid, caffeic acid, and rosmarinic acid have proven to be effective against Leishmania in rodent infectivity studies. Here, we review research on these natural products with a focus on their promise for the development of treatment strategies as well as unique structural and pharmacokinetic/pharmacodynamic features of the most promising agents.

25 January 2022 in Molecules
Verified
Journal Article
Open access
PDF file
BCBrianna Cote
Brianna Cote
Fawzy ElbarbryFawzy Elbarbry
Fawzy Elbarbry
FBFiona Q Bui
Fiona Q Bui
JSJoe Su
Joe Su
KSKaren Seo
Karen Seo
DRDeepa A. Rao
Deepa A. Rao
Chronic inflammatory diseases occur in a large portion of the population and are associated with a poor diet. Key natural products found in fruits and vegetables may assist in lowering inflammation associated with chronic diseases such as obesity, diabetes, cardiovascular diseases, and cancer. This review seeks to examine the roles of several natural products, resveratrol (RES), quercetin (QUE), curcumin (CUR), piperine (PIP), epigallocatechin gallate (EGCG), and gingerol (GIN), in their ability to attenuate inflammatory markers in specific diseases states. Additionally, we will discuss findings in past and ongoing clinical trials, detail possible phytochemical–drug interactions, and provide a brief resource for researchers and healthcare professionals on natural product and supplement regulation as well as names of databases with information on efficacy, indications, and natural product–drug interactions. As diet and over-the-counter supplement use are modifiable factors and patients are interested in using complementary and alternative therapies, understanding the mechanisms by which natural products have demonstrated efficacy and the types of drugs they interact with and knowing where to find information on herbs and supplements is important for practicing healthcare providers and researchers interested in this field.

21 September 2016 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
KAKhaled S. Abdelkawy
Khaled S. Abdelkawy
MBMark E. Balyshev
Mark E. Balyshev
Fawzy ElbarbryFawzy Elbarbry
Fawzy Elbarbry

19 December 2017 in European Journal of Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
Fawzy ElbarbryFawzy Elbarbry
Fawzy Elbarbry

1 September 2009
Verified
Journal Article
Closed access
ARAhmed Ragheb
Ahmed Ragheb
AAAhmed Attia
Ahmed Attia
WSWalid Shehab-Eldin
Walid Shehab-Eldin
Fawzy ElbarbryFawzy Elbarbry
Fawzy Elbarbry
SGSana Gazarin
Sana Gazarin
ASAhmed Shoker
Ahmed Shoker